Drug
Lysine Chloride
Lysine Chloride is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph early_phase_1
2
67%
Ph not_applicable
1
33%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 12 (66.7%)
N/A1 (33.3%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completedearly_phase_1
Mechanism and Effects of Manipulating Chloride Homeostasis in Stable Heart Failure
NCT03440970
completedearly_phase_1
Mechanism and Effects of Manipulating Chloride Homeostasis in Acute Heart Failure
NCT03446651
completednot_applicable
A Pilot Study of Dietary Chloride Supplementation on Cardiorenal Function in Heart Failure
NCT02031354
Clinical Trials (3)
Showing 3 of 3 trials
NCT03440970Early Phase 1
Mechanism and Effects of Manipulating Chloride Homeostasis in Stable Heart Failure
NCT03446651Early Phase 1
Mechanism and Effects of Manipulating Chloride Homeostasis in Acute Heart Failure
NCT02031354Not Applicable
A Pilot Study of Dietary Chloride Supplementation on Cardiorenal Function in Heart Failure
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3